Skip to main content

Sal-Tropine Side Effects

Generic name: atropine

Medically reviewed by Drugs.com. Last updated on Jan 7, 2024.

Note: This document contains side effect information about atropine. Some dosage forms listed on this page may not apply to the brand name Sal-Tropine.

Applies to atropine: intramuscular solution.

Serious side effects of Sal-Tropine

Along with its needed effects, atropine (the active ingredient contained in Sal-Tropine) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking atropine:

More common

Less common

Incidence not known

Other side effects of Sal-Tropine

Some side effects of atropine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

For Healthcare Professionals

Applies to atropine: compounding powder, injectable solution, intramuscular solution, intravenous solution, oral tablet.

General

Although individual reactions vary greatly, systemic doses are likely to produce the following effects:

0.5 mg: Slight dryness of the nose and mouth, bradycardia

1 mg: Greater dryness of nose and mouth with thirst; slowing, then acceleration of the heart; slight mydriasis

2 mg: Very dry mouth, tachycardia with palpitations, mydriasis, slight blurring of near vision

5 mg: Increase in the above symptoms plus disturbance of speech, difficulty swallowing, headache, hot, dry skin, restlessness with asthenia

10 mg and over: Above symptoms to extreme degrees, plus ataxia, excitement, disorientation, hallucinations, delirium, and coma

65 mg: May be fatal[Ref]

Cardiovascular

Common (1% to 10%): Tachycardia (arrhythmias, transient exacerbation of bradycardia)

Very rare (less than 0.01%): Atrial arrhythmias, ventricular fibrillation, angina, hypertensive crisis

Frequency not reported: Bradycardia, slowing then acceleration of heart, palpitations, circulatory collapse, blood pressure declines, sinus tachycardia, supraventricular tachycardia, junctional tachycardia, ventricular tachycardia, ventricular flutter, ventricular fibrillation, atrial arrhythmia, atrial fibrillation, atrial ectopic beats, ventricular premature contractions, bigeminal beats, trigeminal beats, nodal extrasystole, supraventricular extrasystole, asystole, cardiac syncope, prolongation of sinus node recovery time, cardiac dilation, left ventricular failure, myocardial infarction, intermittent nodal rhythm (no P wave), prolonged P wave, shortened PR segment, R on T phenomenon, shortened RT duration, widening and flattening of QRS complex, prolonged QT interval, flattening of T wave, repolarization abnormalities, altered ST-T waves, retrograde conduction, transient AV dissociation, increased blood pressure, labile blood pressure, weak or impalpable peripheral pulses, paradoxical atrioventricular block[Ref]

Nervous system

Very common (10% or more): Loss of taste

Common (1% to 10%): Incoordination

Uncommon (0.1% to 1%): Seizure, drowsiness

Frequency not reported: Disturbance of speech, headache, asthenia, ataxia, coma, dizziness, tremor, locomotor difficulties, medullary paralysis, neurological abnormalities, lethargy, somnolence, syncope, runs of alpha waves on EEG, alpha waves (EEG) blocked upon opening eyes, seizures (generally tonic-clonic), abnormal movements, stupor, amnesia, diminished tendon reflexes, hyperreflexia, opisthotonos, Babinski's reflex/Chaddock's reflex, hypertonia, dysmetria, muscle clonus, sensation of intoxication, difficulty concentrating, vertigo, dysarthria, loss of taste, giddiness, staggering[Ref]

Ocular

Very common (10% or more): Visual disturbances (mydriasis, inhibition of accommodation, blurred vision, photophobia)

Frequency not reported: Blurring of near vision, pupils poorly reactive to light, decreased contrast sensitivity, decreased visual acuity, cycloplegia, strabismus, heterophoria, cyclophoria, acute angle closure glaucoma, conjunctivitis, keratoconjunctivitis sicca, blindness, tearing, dry eyes/dry conjunctiva, irritated eyes, crusting of eyelids, blepharitis, increase in photic stimulation on EEG, increase in intraocular pressure[Ref]

Gastrointestinal

Very common (10% or more): Dryness of mouth (difficulty swallowing and talking, thirst), parasympathetic inhibition of gastrointestinal tract (constipation and reflux), inhibition of gastric secretion, nausea, vomiting, bloated feeling

Frequency not reported: Abdominal distension, abdominal pain, paralytic ileus, decreased bowel sounds, delayed gastric emptying, decreased food absorption, dysphagia, retrosternal pain due to gastric reflux[Ref]

Dermatologic

Very common (10% or more): Anhidrosis, urticaria, rash

Common (1% to 10%): Flushing

Frequency not reported: Dry skin, hot skin, scarlatiniform rash, skin rashes, exfoliation, dry mucus membranes, warm skin, maculopapular rash, erythematous rash, sweating/moist skin, cold skin, cyanosed skin, salivation[Ref]

Psychiatric

Common (1% to 10%): Excitement, confusion, hallucinations

Uncommon (0.1% to 1%): Psychotic reactions

Frequency not reported: Restlessness, disorientation, delirium, loss of libido, delirium, depression, manic behavior, irritability, agitation, insomnia, agitation, paranoia, anxiety, mental disorders, mania, withdrawn behavior, behavior changes, nervousness[Ref]

Other

Common (1% to 10%): Hyperthermia

Frequency not reported: Death, fever, heat intolerance, impairment of temperature regulation (especially in a hot environment), fatigue, hyperpyrexia, chest pain, weakness, feeling hot, signs of drowsiness on EEG[Ref]

Genitourinary

Common (1% to 10%): Inhibition of parasympathetic control of the urinary bladder, urinary retention

Frequency not reported: Urinary hesitancy, impotency, difficulty in micturition, urine urgency, distended urinary bladder, bed wetting[Ref]

Hypersensitivity

Rare (less than 0.1%): Allergic reactions

Very rare (less than 0.01%): Anaphylaxis

Frequency not reported: Hypersensitivity[Ref]

Respiratory

Frequency not reported: Dryness of nose, respiratory failure, tachypnea, slow respirations, shallow respirations, inspiratory stridor, laryngitis, laryngospasm, pulmonary edema, subcostal recession, reduced bronchial secretions, formation of bronchial plugs[Ref]

Metabolic

Frequency not reported: Thirst, excessive thirst, dehydration, hyponatremia, hypokalemia, hypoglycemia, hyperglycemia[Ref]

Musculoskeletal

Frequency not reported: Muscle twitching[Ref]

Local

Frequency not reported: Pain at injection site, local swelling, injection site reaction, redness or other signs of irritation at the injection site[Ref]

Hematologic

Frequency not reported: Leukocytosis, elevated hemoglobin, elevated erythrocytes, low hemoglobin[Ref]

Renal

Frequency not reported: Elevated BUN[Ref]

References

1. Product Information. Atropine Sulfate (atropine). ESI Lederle Generics. 2022.

2. Product Information. Atropine Sulfate (atropine). American Regent Laboratories Inc. 2016.

3. Product Information. AtroPen (atropine). Meridian Medical Technologies Inc. 2003.

4. Cerner Multum, Inc. UK Summary of Product Characteristics.

5. Cerner Multum, Inc. Australian Product Information.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.